Recent studies have shed light on the potential therapeutic properties of these AMPs, including Bogorol B-JX, which has been shown to inhibit the proliferation of human histiocytic lymphoma cell lines and ConA-activated spleen cells [11], and Spergualin, which has demonstrated promising antitumor activity against transplantable leukemias in mice [12]. The gene discussed is ADSL; the disease is reticulum cell sarcoma.